TY  - GEN
AU  - Horneff,Gerd
AU  - Fitter,Sigrid
AU  - Foeldvari,Ivan
AU  - Minden,Kirsten
AU  - Kuemmerle-Deschner,Jasmin
AU  - Tzaribacev,Nicolay
AU  - Thon,Angelika
AU  - Borte,Michael
AU  - Ganser,Gerd
AU  - Trauzeddel,Rolf
AU  - Huppertz,Hans-Iko
TI  - Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement
SN  - 1478-6362
PY  - 2015///0721
KW  - Adalimumab
KW  - Adolescent
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Antirheumatic Agents
KW  - Blood Sedimentation
KW  - Child
KW  - Disability Evaluation
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Severity of Illness Index
KW  - Spondylitis, Ankylosing
KW  - blood
KW  - Treatment Outcome
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/ar4072
ER  -